Skip to main content
Caplight Logo









PreciseDx

PreciseDx

Private
New York City, New YorkHealthcare & Life Scienceshttps://precisedx.ai

Last Round

Early Funding

Sep 23, 2026

Total Funding Raised

$42.45M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

PreciseDx operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B Extension round in June 2025.

PreciseDx is a healthcare technology company that specializes in artificial intelligence-driven pathology diagnostics aimed at enhancing patient outcomes in cancer and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Precision Medicine, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

PreciseDx Comparables

Compare PreciseDx with similar companies based on industry and business-model similarity.

PreciseDx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ataraxis AI
94%
ArteraAI
84%
Virasoft
83%
Book a demo to see all comparables

For institutional investors. Book with your work email.

PreciseDx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingSep 23, 2026
Series B ExtensionJun 18, 2025
Series BAug 21, 2024
Series AJan 11, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Gerardo Fernandez

Chief Scientific Officer and Founder

Founding Team

Eric Converse

Chief Executive Officer, Founding Board Member - Former Interim Chair

Founding Team

Ed Sitar

Chief Financial Officer

Executive Team

For institutional investors. Book with your work email.

PreciseDx Investors

Notable investors and investment history

PreciseDx investors
InvestorRounds
GenHenn CapitalSeries B Extension, Series B
Philips VenturesSeries B Extension
Eventide FundsSeries B Extension, Series B
IBM VenturesSeries A
Hobart HealthcareSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 23, 2026

    Raised $4M in early funding.

  • Aug 21, 2026

    Monthly visitors grew 170% MoM, reaching 2.2K.

Book a demo to see all signals

For institutional investors. Book with your work email.

PreciseDx Filings

Explore SEC and related filing metadata, where available.

PreciseDx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about PreciseDx's valuation, stock price, and market status.

Is PreciseDx a public or private company?

PreciseDx is a private company.

What is the current stock price of PreciseDx?

PreciseDx is a private company, so its shares have no public market price. Caplight tracks PreciseDx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is PreciseDx worth (valuation)?

Valuation information for PreciseDx is not publicly available.

Can I buy PreciseDx stock?

PreciseDx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was PreciseDx's last funding round?

PreciseDx's most recent funding round was Early Funding on September 23, 2026.

Who are the main investors in PreciseDx?

Key investors in PreciseDx include Philips Ventures, Eventide Funds.

Will PreciseDx IPO soon?

No public IPO plans have been announced for PreciseDx.

How can I track PreciseDx secondary market activity?

Caplight tracks bids, offers, and trades in PreciseDx's shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Employee Range23
Year Founded2020
Last FundingSep 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?